New RNA-targeted therapy can halt the progression of a specific type of childhood dementia in mice and holds potential to reverse some of the detrimental effects of this rare disease.
This article was originally published on MedicalXpress.com
New RNA-targeted therapy can halt the progression of a specific type of childhood dementia in mice and holds potential to reverse some of the detrimental effects of this rare disease.
This article was originally published on MedicalXpress.com
© 2024 SimplyWell.ca